EP3328364A4 - Novel dual delayed release oral composition of dexlansoprazole - Google Patents
Novel dual delayed release oral composition of dexlansoprazole Download PDFInfo
- Publication number
- EP3328364A4 EP3328364A4 EP16829940.2A EP16829940A EP3328364A4 EP 3328364 A4 EP3328364 A4 EP 3328364A4 EP 16829940 A EP16829940 A EP 16829940A EP 3328364 A4 EP3328364 A4 EP 3328364A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dexlansoprazole
- delayed release
- oral composition
- release oral
- novel dual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2851MU2015 | 2015-07-28 | ||
PCT/IB2016/054467 WO2017017615A1 (en) | 2015-07-28 | 2016-07-27 | Novel dual delayed release oral composition of dexlansoprazole |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3328364A1 EP3328364A1 (en) | 2018-06-06 |
EP3328364A4 true EP3328364A4 (en) | 2019-01-02 |
Family
ID=57884420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16829940.2A Withdrawn EP3328364A4 (en) | 2015-07-28 | 2016-07-27 | Novel dual delayed release oral composition of dexlansoprazole |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3328364A4 (en) |
BR (1) | BR112018001539A2 (en) |
CL (1) | CL2018000220A1 (en) |
CO (1) | CO2018002046A2 (en) |
PE (1) | PE20181012A1 (en) |
WO (1) | WO2017017615A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111991367A (en) * | 2020-09-21 | 2020-11-27 | 青岛吉达巴尔国际贸易有限公司 | Esomeprazole magnesium pulse pellet capsule and preparation method thereof |
KR102471545B1 (en) * | 2020-11-20 | 2022-11-29 | 서울대학교 산학협력단 | pH-dependent tablet-in-capsule combination formulation containing dexransoprazole as an active ingredient and method for preparing the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010117756A2 (en) * | 2009-03-31 | 2010-10-14 | Dr. Reddy's Laboratories Ltd | Substituted benzimidazole pharmaceutical formulations |
US20120058194A1 (en) * | 2010-08-27 | 2012-03-08 | Navin Vaya | Pharmaceutical formulations comprising substituted benzimidazole derivatives |
WO2013111149A1 (en) * | 2011-12-21 | 2013-08-01 | Hetero Research Foundation | Controlled release solid oral compositions of dexlansoprazole |
-
2016
- 2016-07-27 EP EP16829940.2A patent/EP3328364A4/en not_active Withdrawn
- 2016-07-27 WO PCT/IB2016/054467 patent/WO2017017615A1/en active Application Filing
- 2016-07-27 PE PE2018000128A patent/PE20181012A1/en unknown
- 2016-07-27 BR BR112018001539A patent/BR112018001539A2/en not_active IP Right Cessation
-
2018
- 2018-01-26 CL CL2018000220A patent/CL2018000220A1/en unknown
- 2018-02-26 CO CONC2018/0002046A patent/CO2018002046A2/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010117756A2 (en) * | 2009-03-31 | 2010-10-14 | Dr. Reddy's Laboratories Ltd | Substituted benzimidazole pharmaceutical formulations |
US20120058194A1 (en) * | 2010-08-27 | 2012-03-08 | Navin Vaya | Pharmaceutical formulations comprising substituted benzimidazole derivatives |
WO2013111149A1 (en) * | 2011-12-21 | 2013-08-01 | Hetero Research Foundation | Controlled release solid oral compositions of dexlansoprazole |
Non-Patent Citations (1)
Title |
---|
See also references of WO2017017615A1 * |
Also Published As
Publication number | Publication date |
---|---|
BR112018001539A2 (en) | 2018-09-18 |
EP3328364A1 (en) | 2018-06-06 |
WO2017017615A1 (en) | 2017-02-02 |
CO2018002046A2 (en) | 2018-02-28 |
PE20181012A1 (en) | 2018-06-26 |
CL2018000220A1 (en) | 2018-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3171871A4 (en) | Solid dosage form composition for buccal or sublingual administration of cannabinoids | |
EP3092256A4 (en) | Compounds and compositions for immunotherapy | |
EP3096759A4 (en) | Modified release formulations of pridopidine | |
EP3286213A4 (en) | Methods and compositions for combination immunotherapy | |
EP3242940A4 (en) | Methods and compositions for combination immunotherapy | |
EP3139920A4 (en) | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | |
EP3102555A4 (en) | Compositions of compounds and uses thereof | |
EP3368033A4 (en) | Honey-cannabinoid therapeutic composition | |
EP3332774A4 (en) | Composition for soft capsule coating | |
EP3302439A4 (en) | Therapeutic composition | |
EP3145893A4 (en) | Combined set-delayed cement compositions | |
EP3210613A4 (en) | Composition for external application | |
EP3334409A4 (en) | Solid anhydrous composition comprising combination of waxes | |
EP3360546A4 (en) | Polyphenol-containing solid composition | |
EP3277755A4 (en) | Algae-blended compositions without plasticizers | |
EP3512521A4 (en) | Extended release pharmaceutical composition of clozapine | |
EP3148645A4 (en) | Oral pharmaceutical composition of isotretinoin | |
EP3250562A4 (en) | Crystalline forms of c21h22ci2n4o2 | |
EP3214078A4 (en) | 3-arylbenzofuranone compound and composition formed therefrom | |
EP3403655A4 (en) | Composition for increasing expression of pgc-1 | |
EP3384966A4 (en) | Fire-extinguishing composition | |
EP3253403A4 (en) | Methods and compositions for improved cognition | |
EP3378585A4 (en) | Bonding composition | |
EP3302467A4 (en) | Combination compositions for immunotherapy | |
EP3375432A4 (en) | Oral cavity composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180222 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20181203 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/48 20060101ALI20181127BHEP Ipc: A61K 9/50 20060101AFI20181127BHEP Ipc: A61K 9/62 20060101ALI20181127BHEP Ipc: A61K 31/4439 20060101ALI20181127BHEP Ipc: A61K 9/58 20060101ALI20181127BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20210202 |